These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 18806740
41. The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells. Podtcheko A, Ohtsuru A, Tsuda S, Namba H, Saenko V, Nakashima M, Mitsutake N, Kanda S, Kurebayashi J, Yamashita S. J Clin Endocrinol Metab; 2003 Apr; 88(4):1889-96. PubMed ID: 12679488 [Abstract] [Full Text] [Related]
42. Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo. Ain KB, Tofiq S, Taylor KD. J Clin Endocrinol Metab; 1996 Oct; 81(10):3650-3. PubMed ID: 8855817 [Abstract] [Full Text] [Related]
43. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. Mitsiades CS, McMillin D, Kotoula V, Poulaki V, McMullan C, Negri J, Fanourakis G, Tseleni-Balafouta S, Ain KB, Mitsiades N. J Clin Endocrinol Metab; 2006 Oct; 91(10):4013-21. PubMed ID: 16849420 [Abstract] [Full Text] [Related]
44. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S. Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571 [Abstract] [Full Text] [Related]
45. pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A. Clin Cancer Res; 2004 Dec 01; 10(23):8085-93. PubMed ID: 15585644 [Abstract] [Full Text] [Related]
46. Evodiamine selectively targets cancer stem-like cells through the p53-p21-Rb pathway. Han S, Woo JK, Jung Y, Jeong D, Kang M, Yoo YJ, Lee H, Oh SH, Ryu JH, Kim WY. Biochem Biophys Res Commun; 2016 Jan 22; 469(4):1153-8. PubMed ID: 26713361 [Abstract] [Full Text] [Related]
47. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP, Darzynkiewicz Z. Cancer Res; 2000 Aug 01; 60(15):4139-45. PubMed ID: 10945621 [Abstract] [Full Text] [Related]
48. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Mantovani F, Tocco F, Girardini J, Smith P, Gasco M, Lu X, Crook T, Del Sal G. Nat Struct Mol Biol; 2007 Oct 01; 14(10):912-20. PubMed ID: 17906639 [Abstract] [Full Text] [Related]
49. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, Hsu SL. Int J Cancer; 2002 Jul 10; 100(2):158-65. PubMed ID: 12115564 [Abstract] [Full Text] [Related]
50. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Menendez JA, Vellon L, Colomer R, Lupu R. Int J Cancer; 2005 May 20; 115(1):19-35. PubMed ID: 15657900 [Abstract] [Full Text] [Related]
51. Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Takahashi K, Akiyama H, Shimazaki K, Uchida C, Akiyama-Okunuki H, Tomita M, Fukumoto M, Uchida T. Oncogene; 2007 May 31; 26(26):3835-45. PubMed ID: 17160015 [Abstract] [Full Text] [Related]
52. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice. Wang YJ, Jeng JH, Chen RJ, Tseng H, Chen LC, Liang YC, Lin CH, Chen CH, Chu JS, Ho WL, Ho YS. Mol Carcinog; 2002 Aug 31; 34(4):199-210. PubMed ID: 12203371 [Abstract] [Full Text] [Related]
53. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M. Hepatology; 2001 May 31; 33(5):1087-97. PubMed ID: 11343236 [Abstract] [Full Text] [Related]
54. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Miyashita H, Mori S, Motegi K, Fukumoto M, Uchida T. Oncol Rep; 2003 May 31; 10(2):455-61. PubMed ID: 12579289 [Abstract] [Full Text] [Related]
56. Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells. Toko H, Hariharan N, Konstandin MH, Ormachea L, McGregor M, Gude NA, Sundararaman B, Joyo E, Joyo AY, Collins B, Din S, Mohsin S, Uchida T, Sussman MA. J Biol Chem; 2014 Feb 28; 289(9):5348-56. PubMed ID: 24375406 [Abstract] [Full Text] [Related]
57. Pin1 mediates neural-specific activation of the mitochondrial apoptotic machinery. Becker EB, Bonni A. Neuron; 2006 Mar 02; 49(5):655-62. PubMed ID: 16504941 [Abstract] [Full Text] [Related]
58. Inhibition of peptidyl-prolyl cis/trans isomerase Pin1 induces cell cycle arrest and apoptosis in vascular smooth muscle cells. Lv L, Zhou Z, Huang X, Zhao Y, Zhang L, Shi Y, Sun M, Zhang J. Apoptosis; 2010 Jan 02; 15(1):41-54. PubMed ID: 19904610 [Abstract] [Full Text] [Related]
59. Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G. Endocr Relat Cancer; 2007 Sep 02; 14(3):839-45. PubMed ID: 17914112 [Abstract] [Full Text] [Related]
60. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. Yang Q, Ji M, Guan H, Shi B, Hou P. J Clin Endocrinol Metab; 2013 Dec 02; 98(12):E1909-17. PubMed ID: 24106286 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]